About Lexent Bio
Lexent Bio is a company based in San Diego (United States) founded in 2017 was acquired by Foundation Medicine in June 2020. Lexent Bio operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Foundation Medicine
(Jun 12, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lexent Bio
Detailed funding history for Lexent Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Lexent Bio
Lexent Bio has secured backing from 1 investor. Prominent investors backing the company include Foundation Medicine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Genomics-based diagnostic tests for cancer are provided.
|
Locked | Locked | Locked |
Investor details for Lexent Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lexent Bio
Investment portfolio details for Lexent Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lexent Bio
Detailed financials for Lexent Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lexent Bio Comparisons
Peer comparison for Lexent Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lexent Bio
Lexent Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Delfi Diagnostics and BillionToOne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing for cancer detection
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
Detailed competitors of Lexent Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lexent Bio
Complete news archive for Lexent Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lexent Bio
Lexent Bio was founded in 2017.
Lexent Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Lexent Bio was founded in 2017 and is headquartered in San Diego, United States. Operations in the biotechnology sector focus on bioinformatics and genomic science for cancer diagnosis. Comprehensive genomic profiling assays are delivered to detect molecular alterations in patients tumors and align them with targeted therapies and immunotherapies. Services support clinical decision-making in oncology.
Lexent Bio's top competitors include Guardant Health, GRAIL and BillionToOne.
Lexent Bio has 1 investor. Key investors include Foundation Medicine.